Selected article for: "disease course and mild disease patient"
Author: Christine Dahlke; Jasmin Heidepriem; Robin Kobbe; Rene Santer; Till Koch; Anahita Fathi; My L. Ly; Stefan Schmiedel; Peter H. Seeberger; Marylyn M. Addo; Felix F. Loeffler
Title: Distinct early IgA profile may determine severity of COVID-19 symptoms: an immunological case series
  • Document date: 2020_4_17
    • ID: icl1t9d6_34
    Snippet: We detected an early and defined IgA response in patient #2 who had a very mild course of disease. In addition, our patient #4 (mild/moderate course of disease, no hospitalization, see Supporting Information Figures S1 & S2) also showed an early IgA response. IgA is considered a major effector molecule involved in defense mechanisms against viruses and infections with respiratory viruses can induce efficient IgA responses in secretions as well as.....
    Document: We detected an early and defined IgA response in patient #2 who had a very mild course of disease. In addition, our patient #4 (mild/moderate course of disease, no hospitalization, see Supporting Information Figures S1 & S2) also showed an early IgA response. IgA is considered a major effector molecule involved in defense mechanisms against viruses and infections with respiratory viruses can induce efficient IgA responses in secretions as well as in sera. Our data suggest that IgA antibodies are valuable diagnostic markers that show All rights reserved. No reuse allowed without permission.

    Search related documents:
    Co phrase search for related documents
    • defense mechanism and respiratory virus: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • diagnostic marker and infection virus: 1, 2
    • diagnostic marker and respiratory virus: 1
    • disease mild course and infection virus: 1, 2, 3
    • disease mild course and mild course: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • disease mild course and mild moderate course: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • disease mild course and respiratory virus: 1, 2, 3, 4, 5
    • disease mild moderate course and mild course: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • disease mild moderate course and mild moderate course: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • disease mild moderate course and respiratory virus: 1
    • early iga response and IgA antibody: 1, 2, 3, 4, 5
    • early iga response and iga response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • early iga response and patient iga response: 1
    • effector molecule and infection virus: 1, 2, 3, 4
    • IgA antibody and infection virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • IgA antibody and mild course: 1, 2, 3
    • IgA antibody and patient iga response: 1, 2
    • IgA antibody and respiratory virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • iga response and respiratory virus: 1, 2, 3, 4, 5, 6, 7, 8, 9